 The fresh reports by the newspaper "The Saturday Star" suggested investments between 2000 and 2001 that tapered off after the trials in Tanzania were aborted, allegations denied by the Presidency.Initial funding came from the controversial cryonics (low temperature preservation of humans after death) company Alcor Life.The funding came because of the main Virodene founder's research into the freezing and thawing of animal hearts.